Aquestive Therapeutics, Inc.·4

Sep 29, 4:26 PM ET

Barber Daniel 4

4 · Aquestive Therapeutics, Inc. · Filed Sep 29, 2025

Insider Transaction Report

Form 4
Period: 2025-09-26
Barber Daniel
President and CEO
Transactions
  • Sale

    Common Stock

    2025-09-26$6.03/sh91,343$551,191923,430 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.
  • [F2]The reported transaction involves sale transactions from $6.00 to $6.11 per share. The weighted average price per share was $6.0343. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    marketforms-70872.xmlPrimary

    PRIMARY DOCUMENT